Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Outbreak of Monkeypox Virus Disease: An Update on Epidemiology, Pathophysiology and Available Treatment Options

Author(s): Akash Kumar, Neeti Angaria, Gurvinder Singh and Rajesh Kumar*

Volume 23, Issue 6, 2023

Published on: 26 May, 2023

Article ID: e180423216001 Pages: 14

DOI: 10.2174/1871526523666230418121045

Price: $65

Open Access Journals Promotions 2
conference banner
Abstract

The monkeypox virus is a zoonotic illness with a tropical distribution in Africa, and around the world. The disease is spread through contact with infected animals or humans, and can also be spread from person to person through close contact with respiratory or bodily fluids. Fever, swollen lymph nodes, blisters, and crusted rashes characterize the disease. The incubation period is five to twenty-one days. It is difficult to distinguish the rash caused by infection from varicella and smallpox. Laboratory investigations are essential aspects of illness diagnosis and surveillance, and novel tests are required for more accurate and faster diagnosis. Antiviral drugs are being used to treat monkeypox. Scarring as well as other comorbidities, are prevalent in survivors, with the case mortality rate varying from 1 to 11%. The virus was found in monkeys at a Danish research facility in 1958, from which the term ‘monkeypox’ is derived. The primary human case was found in a child in the Democratic Republic of the Congo (DRC) in 1970. The World Health Organisation (WHO) has recently declared monkeypox a public health emergency of international concern. This manuscript attempts to review the various aspects of monkeypox disease and its allopathic as well as alternative treatment options available and serves as a valuable resource for healthcare professionals, researchers, and the general public.

Keywords: Monkeypox, smallpox, chickenpox, outbreak, zoonotic viral disease, herbs, antivirals.

Graphical Abstract

[1]
WHO. Monkeypox outbreak. 2022. Available from: https://www.who.int/emergencies/situations/monkeypox-oubreak-2022
[2]
Petersen E, Kantele A, Koopmans M, et al. Human monkeypox: Epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin 2019; 33(4): 1027-43.
[PMID: 30981594]
[3]
Kmiec D, Kirchhoff F. Monkeypox: A new threat? Int J Mol Sci 2022; 23(14): 7866.
[http://dx.doi.org/10.3390/ijms23147866] [PMID: 35887214]
[4]
Buller RM, Palumbo GJ. Poxvirus pathogenesis. Microbiol Rev 1991; 55(1): 80-122.
[http://dx.doi.org/10.1128/mr.55.1.80-122.1991] [PMID: 1851533]
[5]
Walsh D. Poxviruses: Slipping and sliding through transcription and translation. PLoS Pathog 2017; 13(11): e1006634.
[http://dx.doi.org/10.1371/journal.ppat.1006634] [PMID: 29145493]
[6]
Ogoina D, Izibewule JH, Ogunleye A, et al. The 2017 human monkeypox outbreak in Nigeria-Report of outbreak experience and response in the Niger Delta University Teaching Hospital, Bayelsa State, Nigeria. PLoS One 2019; 14(4): e0214229.
[http://dx.doi.org/10.1371/journal.pone.0214229] [PMID: 30995249]
[7]
Oliveira G, Rodrigues R, Lima M, Drumond B, Abrahão J. Poxvirus host range genes and virus–host spectrum: A critical review. Viruses 2017; 9(11): 331.
[http://dx.doi.org/10.3390/v9110331] [PMID: 29112165]
[8]
Adler H, Gould S, Hine P, et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis 2022; 22(8): 1153-62.
[http://dx.doi.org/10.1016/S1473-3099(22)00228-6] [PMID: 35623380]
[9]
Ježek Z, Grab B, Szczeniowski MV, Paluku KM, Mutombo M. Human monkeypox: Secondary attack rates. Bull World Health Organ 1988; 66(4): 465-70.
[PMID: 2844429]
[10]
Heymann DL, Szczeniowski M, Esteves K. Re-emergence of monkeypox in Africa: A review of the past six years. Br Med Bull 1998; 54(3): 693-702.
[http://dx.doi.org/10.1093/oxfordjournals.bmb.a011720] [PMID: 10326294]
[11]
Breman JG, Kalisa-Ruti , Steniowski MV, Zanotto E, Gromyko AI, Arita I. Human monkeypox, 1970-79. Bull World Health Organ 1980; 58(2): 165-82.
[PMID: 6249508]
[12]
Mbala PK, Huggins JW, Riu-Rovira T, et al. Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo. J Infect Dis 2017; 216(7): 824-8.
[http://dx.doi.org/10.1093/infdis/jix260] [PMID: 29029147]
[13]
Shchelkunov SN. An increasing danger of zoonotic orthopoxvirus infections. PLoS Pathog 2013; 9(12): e1003756.
[http://dx.doi.org/10.1371/journal.ppat.1003756] [PMID: 24339772]
[14]
Ladnyj ID, Ziegler P, Kima E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ 1972; 46(5): 593-7.
[PMID: 4340218]
[15]
Sklenovská N, Van Ranst M. Emergence of monkeypox as the most important orthopoxvirus infection in humans. Front Public Health 2018; 6: 241.
[http://dx.doi.org/10.3389/fpubh.2018.00241] [PMID: 30234087]
[16]
Bunge EM, Hoet B, Chen L, et al. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis 2022; 16(2): e0010141.
[http://dx.doi.org/10.1371/journal.pntd.0010141] [PMID: 35148313]
[17]
Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl Trop Dis 2019; 13(10): e0007791.
[http://dx.doi.org/10.1371/journal.pntd.0007791] [PMID: 31618206]
[18]
Di Giulio DB, Eckburg PB. Human monkeypox: An emerging zoonosis. Lancet Infect Dis 2004; 4(1): 15-25.
[http://dx.doi.org/10.1016/S1473-3099(03)00856-9] [PMID: 14720564]
[19]
Nakazawa Y, Mauldin M, Emerson G, et al. A phylogeographic investigation of African monkeypox. Viruses 2015; 7(4): 2168-84.
[http://dx.doi.org/10.3390/v7042168] [PMID: 25912718]
[20]
ANI. New Delhi: India's tally of Monkeypox now stands at 19 after Nigerian tests positive for virus. 2022. Available from: https://www.aninews.in/news/national/general-news/new-delhi-indias-tally-of-monkeypox-now-stands-at-19-after-nigerian-tests-positive-for-virus20221025195606/
[21]
Mahase E. Seven monkeypox cases are confirmed in England. BMJ 2022; 377: o1239.
[http://dx.doi.org/10.1136/bmj.o1239] [PMID: 35580887]
[22]
Rao AK, Schulte J, Chen TH, et al. Monkeypox in a traveler returning from Nigeria-Dallas, Texas, July 2021. MMWR Morb Mortal Wkly Rep 2022; 71(14): 509-16.
[http://dx.doi.org/10.15585/mmwr.mm7114a1] [PMID: 35389974]
[23]
Costello V, Sowash M, Gaur A, et al. Imported monkeypox from international traveler, Maryland, USA, 2021. Emerg Infect Dis 2022; 28(5): 1002-5.
[http://dx.doi.org/10.3201/eid2805.220292] [PMID: 35263559]
[24]
WHO. Multi-country outbreak of monkeypox. 2022. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20220725_monkeypox_external_sitrep_2_final.pdf?sfvrsn=c41fc2dd_3&download=true
[25]
Kugelman JR, Johnston SC, Mulembakani PM, et al. Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo. Emerg Infect Dis 2014; 20(2): 232-9.
[http://dx.doi.org/10.3201/eid2002.130118] [PMID: 24457084]
[26]
Alakunle EF, Okeke MI. Monkeypox virus: A neglected zoonotic pathogen spreads globally. Nat Rev Microbiol 2022; 20(9): 507-8.
[http://dx.doi.org/10.1038/s41579-022-00776-z] [PMID: 35859005]
[27]
Prevention CfDCa. Monkeypox Outbreak Global Map. 2022. Available from: https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html
[28]
Kaler J, Hussain A, Flores G, Kheiri S, Desrosiers D. Monkeypox: A comprehensive review of transmission, pathogenesis, and manifestation. Cureus 2022; 14(7): e26531.
[http://dx.doi.org/10.7759/cureus.26531] [PMID: 35928395]
[29]
Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox virus infection in humans across 16 countries-April-June 2022. N Engl J Med 2022; 387(8): 679-91.
[http://dx.doi.org/10.1056/NEJMoa2207323] [PMID: 35866746]
[30]
Rao AK, Petersen BW, Whitehill F, et al. Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: Recommendations of the advisory committee on immunization practices — United States, 2022. MMWR Morb Mortal Wkly Rep 2022; 71(22): 734-42.
[http://dx.doi.org/10.15585/mmwr.mm7122e1] [PMID: 35653347]
[31]
Titanji BK, Tegomoh B, Nematollahi S, Konomos M, Kulkarni PA, Eds. Monkeypox: a contemporary review for healthcare professionals Open forum infectious diseases. Oxford University Press 2022.
[32]
PREVENTION CFDCA. Monkeypox. 2022. Available from: https://www.cdc.gov/poxvirus/monkeypox/index.html
[33]
Bray M, Buller M. Looking back at smallpox. Clin Infect Dis 2004; 38(6): 882-9.
[http://dx.doi.org/10.1086/381976] [PMID: 14999635]
[34]
Vaughan A, Aarons E, Astbury J, et al. Two cases of monkeypox imported to the United Kingdom, September 2018. Euro Surveill 2018; 23(38): 1800509.
[http://dx.doi.org/10.2807/1560-7917.ES.2018.23.38.1800509] [PMID: 30255836]
[35]
Jezek Z, Szczeniowski M, Paluku KM, Mutombo M, Grab B. Human monkeypox: Confusion with chickenpox. Acta Trop 1988; 45(4): 297-307.
[PMID: 2907258]
[36]
Nolen LD, Osadebe L, Katomba J, et al. Extended human-to-human transmission during a monkeypox outbreak in the Democratic Republic of the Congo. Emerg Infect Dis 2016; 22(6): 1014-21.
[http://dx.doi.org/10.3201/eid2206.150579] [PMID: 27191380]
[37]
Feng J, Xue G, Cui X, et al. Development of a loop-mediated isothermal amplification method for rapid and visual detection of monkeypox virus. Microbiol Spectr 2022; 10(5): e02714-22.
[http://dx.doi.org/10.1128/spectrum.02714-22] [PMID: 36154444]
[38]
Davi SD, Kissenkötter J, Faye M, et al. Recombinase polymerase amplification assay for rapid detection of Monkeypox virus. Diagn Microbiol Infect Dis 2019; 95(1): 41-5.
[http://dx.doi.org/10.1016/j.diagmicrobio.2019.03.015] [PMID: 31126795]
[39]
Loparev VN, Massung RF, Esposito JJ, Meyer H. Detection and differentiation of old world orthopoxviruses: restriction fragment length polymorphism of the crmB gene region. J Clin Microbiol 2001; 39(1): 94-100.
[http://dx.doi.org/10.1128/JCM.39.1.94-100.2001] [PMID: 11136755]
[40]
Porzucek AJ, Proctor AM, Klinkhammer KE, et al. Development of an accessible and scalable quantitative polymerase chain reaction assay for monkeypox virus detection. J Infect Dis 2023; 227(9): 1084-7.
[http://dx.doi.org/10.1093/infdis/jiac414]
[41]
Control ECfDPa. Risk assessment: Monkeypox multi-country outbreak. 2022. Available from: https://www.ecdc.europa.eu/en/publications-data/risk-assessment-monkeypox-multi-country-outbreak
[42]
Ministry of Health and Family Welfare GoI. Guidelines for management of Monkeypox disease. 2022. Available from: https://main.mohfw.gov.in/sites/default/files/Guidelines%20for%20Management%20of%20Monkeypox%20Disease.pdf
[43]
Hammarlund E, Lewis MW, Carter SV, et al. Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox. Nat Med 2005; 11(9): 1005-11.
[http://dx.doi.org/10.1038/nm1273] [PMID: 16086024]
[44]
Mucker EM, Chapman J, Huzella LM, et al. Susceptibility of marmosets (Callithrix jacchus) to monkeypox virus: A low dose prospective model for monkeypox and smallpox disease. PLoS One 2015; 10(7): e0131742.
[http://dx.doi.org/10.1371/journal.pone.0131742] [PMID: 26147658]
[45]
Xu H, Krieter AL, Ponnuraj N, Tien YYT, Kim T, Jarosinski KW. Coinfection in the host can result in functional complementation between live vaccines and virulent virus. Virulence 2022; 13(1): 980-9.
[http://dx.doi.org/10.1080/21505594.2022.2082645] [PMID: 35658809]
[46]
PREVENTION CFDCA. Treatment Information for Healthcare Professionals. 2022. Available from: https://www.cdc.gov/poxvirus/monkeypox/clinicians/treatment.html
[47]
AGENCY EM. Tecovirimat SIGA. 2022. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/tecovirimat-siga
[48]
USFDA. FDA approves the first drug with an indication for treatment of smallpox 2022. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-indication-treatment-smallpox
[49]
Russo AT, Berhanu A, Bigger CB, et al. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge. Vaccine 2020; 38(3): 644-54.
[http://dx.doi.org/10.1016/j.vaccine.2019.10.049] [PMID: 31677948]
[50]
USFDA. FDA approves drug to treat smallpox. 2021. Available from: https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-drug-treat-smallpox
[51]
Vora S, Damon I, Fulginiti V, et al. Severe eczema vaccinatum in a household contact of a smallpox vaccinee. Clin Infect Dis 2008; 46(10): 1555-61.
[http://dx.doi.org/10.1086/587668] [PMID: 18419490]
[52]
USFDA. accinia Immune Globulin Intravenous (Human). 2018. Available from: https://www.fda.gov/vaccines-blood-biologics/approved-blood-products/vaccinia-immune-globulin-intravenous-human
[53]
Parker S, Crump R, Foster S, et al. Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus. Antiviral Res 2014; 111: 42-52.
[http://dx.doi.org/10.1016/j.antiviral.2014.08.003] [PMID: 25128688]
[54]
Lederman ER, Davidson W, Groff HL, et al. Progressive vaccinia: Case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001. J Infect Dis 2012; 206(9): 1372-85.
[http://dx.doi.org/10.1093/infdis/jis510] [PMID: 22904336]
[55]
McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis 2014; 58(2): 260-7.
[http://dx.doi.org/10.1093/cid/cit703] [PMID: 24158414]
[56]
Stittelaar KJ, van Amerongen G, Kondova I, et al. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus. J Virol 2005; 79(12): 7845-51.
[http://dx.doi.org/10.1128/JVI.79.12.7845-7851.2005] [PMID: 15919938]
[57]
Kumar N, Acharya A, Gendelman HE, Byrareddy SN. The 2022 outbreak and the pathobiology of the monkeypox virus. J Autoimmun 2022; 131: 102855.
[http://dx.doi.org/10.1016/j.jaut.2022.102855] [PMID: 35760647]
[58]
Earl PL, Americo JL, Wyatt LS, et al. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature 2004; 428(6979): 182-5.
[http://dx.doi.org/10.1038/nature02331] [PMID: 15014500]
[59]
O’Laughlin K, Tobolowsky FA, Elmor R, et al. Clinical use of Tecovirimat (Tpoxx) for treatment of monkeypox under an investigational new drug protocol — United States, May–August 2022 In: Weekly. 2022; 71: pp. (37)1190-5.
[60]
Berhanu A, Prigge JT, Silvera PM, Honeychurch KM, Hruby DE, Grosenbach DW. Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection. Antimicrob Agents Chemother 2015; 59(7): 4296-300.
[http://dx.doi.org/10.1128/AAC.00208-15] [PMID: 25896687]
[61]
Rizk JG, Lippi G, Henry BM, Forthal DN, Rizk Y. Prevention and treatment of monkeypox. Drugs 2022; 82(9): 957-63.
[http://dx.doi.org/10.1007/s40265-022-01742-y] [PMID: 35763248]
[62]
Hutson CL, Kondas AV, Mauldin MR, et al. Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model. MSphere 2021; 6(1): e00927-20.
[PMID: 33536322]
[63]
Poland GA, Kennedy RB, Tosh PK. Prevention of monkeypox with vaccines: A rapid review. Lancet Infect Dis 2022; 22(12): e349-58.
[http://dx.doi.org/10.1016/S1473-3099(22)00574-6] [PMID: 36116460]
[64]
Hazra A, Rusie L, Hedberg T, Schneider JA. Human monkeypox virus infection in the immediate period after receiving modified vaccinia Ankara vaccine. JAMA 2022; 328(20): 2064-7.
[http://dx.doi.org/10.1001/jama.2022.18320] [PMID: 36178700]
[65]
Holý A. Antiviral acyclic nucleoside phosphonates structure activity studies. Antiviral Res 2006; 71(2-3): 248-53.
[http://dx.doi.org/10.1016/j.antiviral.2006.06.002] [PMID: 16857275]
[66]
Myskiw C, Deschambault Y, Jefferies K, He R, Cao J. Aurintricarboxylic acid inhibits the early stage of vaccinia virus replication by targeting both cellular and viral factors. J Virol 2007; 81(6): 3027-32.
[http://dx.doi.org/10.1128/JVI.02531-06] [PMID: 17192307]
[67]
Henderson DA. The eradication of smallpox-an overview of the past, present, and future. Vaccine 2011; 29 (Suppl. 4): D7-9.
[http://dx.doi.org/10.1016/j.vaccine.2011.06.080] [PMID: 22188929]
[68]
Dhawan BN. Anti-viral activity of Indian plants. Proc Natl Acad Sci, India, Sect B Biol Sci 2012; 82(1): 209-24.
[http://dx.doi.org/10.1007/s40011-011-0016-7] [PMID: 32226204]
[69]
Arndt W, Mitnik C, Denzler KL, et al. In vitro characterization of a nineteenth-century therapy for smallpox. PLoS One 2012; 7(3): e32610.
[http://dx.doi.org/10.1371/journal.pone.0032610] [PMID: 22427855]
[70]
Karagatzides JD, Butler JL, Ellison AM. The pitcher plant Sarracenia purpurea can directly acquire organic nitrogen and short-circuit the inorganic nitrogen cycle. PLoS One 2009; 4(7): e6164.
[http://dx.doi.org/10.1371/journal.pone.0006164] [PMID: 19582167]
[71]
Uzzaman S. Pharmacological activities of neem (Azadirachta indica): A review. Int J Pharmacog Life Sci 2020; 1(1): 38-41.
[http://dx.doi.org/10.33545/27072827.2020.v1.i1a.8]
[72]
Kumar A, Rahal A, Chakraborty S, Tiwari R, Latheef SK, Dhama K. Ocimum sanctum (Tulsi): A miracle herb and boon to medical science-A Review. Int J Agron Plant Prod 2013; 4(7): 1580-9.
[73]
Priya F, Islam MS. Phyllanthus emblica Linn.(Amla)—a natural gift to humans: An overview. J Dis Med Plants 2019; 5: 1-9.
[74]
Ekka R, Dogra E, Nair PG, et al. Effect of add-on Ayurveda treatment in the management of chickenpox. J Res Ayurvedic Sci 2021; 5(4): 173.
[75]
Ellison AM, Buckley HL, Miller TE, Gotelli NJ. Morphological variation in Sarracenia purpurea (Sarraceniaceae): Geographic, environmental and taxonomic correlates. Am J Bot 2004; 91(11): 1930-5.
[http://dx.doi.org/10.3732/ajb.91.11.1930] [PMID: 21652339]
[76]
Popovych V, Koshel I, Malofiichuk A, et al. A randomized, open-label, multicenter, comparative study of therapeutic efficacy, safety and tolerability of BNO 1030 extract, containing marshmallow root, chamomile flowers, horsetail herb, walnut leaves, yarrow herb, oak bark, dandelion herb in the treatment of acute non-bacterial tonsillitis in children aged 6 to 18 years. Am J Otolaryngol 2019; 40(2): 265-73.
[http://dx.doi.org/10.1016/j.amjoto.2018.10.012] [PMID: 30554882]
[77]
Zazharskyi VV, Davydenko PO, Kulishenko OМ, Borovik IV, Brygadyrenko VV. Antimicrobial activity of 50 plant extracts. Biosyst Divers 2019; 27(2): 163-9.
[http://dx.doi.org/10.15421/011922]
[78]
Pedley TF. Treatment of small-pox by tincture of iodine. Ind Med Gaz 1912; 47(11): 435.
[PMID: 29005403]
[79]
Abubakar IB, Kankara SS, Malami I, et al. Traditional medicinal plants used for treating emerging and re-emerging viral diseases in northern Nigeria. Eur J Integr Med 2022; 49: 102094.
[http://dx.doi.org/10.1016/j.eujim.2021.102094] [PMID: 36573184]
[80]
Yagnik D, Ward M, Shah AJ. Antibacterial apple cider vinegar eradicates methicillin resistant Staphylococcus aureus and resistant Escherichia coli. Sci Rep 2021; 11(1): 1854.
[http://dx.doi.org/10.1038/s41598-020-78407-x] [PMID: 33473148]
[81]
Srivastava JK, Shankar E, Gupta S. Chamomile: A herbal medicine of the past with bright future. Mol Med Rep 2010; 3(6): 895-901.
[PMID: 21132119]
[82]
Bhanuprakash V, Hosamani M, Balamurugan V, Singh R, Swarup D. In vitro antiviral activity of Eugenia jambolana plant extract on buffalopox virus: Conventional and QPCR methods. Int J Trop Med 2007; 2(1): 3-9.
[83]
Percival SS. Use of Echinacea in medicine. Biochem Pharmacol 2000; 60(2): 155-8.
[http://dx.doi.org/10.1016/S0006-2952(99)00413-X] [PMID: 10825459]
[84]
Moy RL, Levenson C. Sandalwood album oil as a botanical therapeutic in dermatology. J Clin Aesthet Dermatol 2017; 10(10): 34-9.
[PMID: 29344319]
[85]
Watanabe K, Rahmasari R, Matsunaga A, Haruyama T, Kobayashi N. Anti-influenza viral effects of honey in vitro: potent high activity of manuka honey. Arch Med Res 2014; 45(5): 359-65.
[http://dx.doi.org/10.1016/j.arcmed.2014.05.006] [PMID: 24880005]
[86]
Sagaya Jansi R, Khusro A, Agastian P, et al. Emerging paradigms of viral diseases and paramount role of natural resources as antiviral agents. Sci Total Environ 2021; 759: 143539.
[http://dx.doi.org/10.1016/j.scitotenv.2020.143539] [PMID: 33234268]
[87]
Healthline. Uses for Calamine Lotion and How to Apply. 2019. Available from: https://www.healthline.com/health/calamine-lotion-uses
[88]
Feily A, Kazerouni A, Pazyar N, Yaghoobi R. Oatmeal in dermatology: A brief review. Indian J Dermatol Venereol Leprol 2012; 78(2): 142-5.
[http://dx.doi.org/10.4103/0378-6323.93629] [PMID: 22421643]
[89]
Eaton CW. The facts about variolinum. American J Homeopathic Med 2014; 107(2) Available from: http://www.homeoint.org/winston/variolinum.htm
[90]
Gibson DM. Antimonium tartaricum, a study. Br Homeopath J 1965; 54(4): 270-3.
[http://dx.doi.org/10.1016/S0007-0785(65)80061-8]
[91]
dos Santos AL, Perazzo FF, Cardoso LGV, Carvalho JCT. In vivo study of the anti-inflammatory effect of Rhus toxicodendron. Homeopathy 2007; 96(2): 95-101.
[http://dx.doi.org/10.1016/j.homp.2007.03.001] [PMID: 17437936]
[92]
Mahesh S, Kozymenko T, Kolomiiets N, Vithoulkas G. Antimonium crudum in pediatric skin conditions: A classical homeopathic case series. Clin Case Rep 2021; 9(2): 818-24.
[http://dx.doi.org/10.1002/ccr3.3674] [PMID: 33598251]
[93]
Ive EC, Couchman IMS, Reddy L. Therapeutic effect of Arsenicum album on leukocytes. Int J Mol Sci 2012; 13(3): 3979-87.
[http://dx.doi.org/10.3390/ijms13033979] [PMID: 22489193]
[94]
Marriott KA, Parkinson CV, Morefield SI, Davenport R, Nichols R, Monath TP. Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge. Vaccine 2008; 26(4): 581-8.
[http://dx.doi.org/10.1016/j.vaccine.2007.10.063] [PMID: 18077063]
[95]
Kisalu NK, Mokili JL. Toward understanding the outcomes of monkeypox infection in human pregnancy. Oxford University Press US 2017; pp. 795-7.
[96]
Falendysz EA, Lopera JG, Lorenzsonn F, et al. Further assessment of monkeypox virus infection in Gambian pouched rats (Cricetomys gambianus) using in vivo bioluminescent imaging. PLoS Negl Trop Dis 2015; 9(10): e0004130.
[http://dx.doi.org/10.1371/journal.pntd.0004130] [PMID: 26517839]
[97]
NETEC. Waste management from patients being treated for monkeypox virus. 2021. Available from: https://netec.org/2021/07/21/monkeypox-waste-management/
[98]
Lowe JJ, Jelden K. Strategies for waste management and decontamination. In: Bioemergency Planning. 2018; pp. 53-66.
[http://dx.doi.org/10.1007/978-3-319-77032-1_5]
[99]
WHO. Multi-country monkeypox outbreak: situation update. 2022. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON393
[100]
Antinori A, Mazzotta V, Vita S, et al. Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022. Euro Surveill 2022; 27(22): 2200421.
[http://dx.doi.org/10.2807/1560-7917.ES.2022.27.22.2200421] [PMID: 35656836]
[101]
NEWS C. Montreal public health shifting vaccination plan as monkeypox cases grow to 126. 2022. Available from: https://montreal.ctvnews.ca/montreal-public-health-%20shifting-vaccination-plan-as-monkeypox-cases-grow-to-126-1.5946380

Rights & Permissions Print Cite
Article Metrics
18
3
Wayfinder Image
Open Access Journals Promotions
© 2024 Bentham Science Publishers | Privacy Policy